These causes are impaired mitochondrial function, differentiation of insulin-mediated glucose metabolism, the increased metabolic activity of more aggressive tumor biology, the pharmacokinetics of the drugs, decreased myokine production, poor nutritional status, decreased quality of life, physical disability, and increased mortality rate. This evidence concerns the gene INS and neoplasm.